Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan

Background: This study compared the adverse events (AEs) of the second and third doses of BNT162b2, as well as investigated the impact of vaccine recipients’ background and vaccination interval on the AEs of the third dose. Methods: We conducted a questionnaire survey of AEs among health care worker...

Descripción completa

Detalles Bibliográficos
Autores principales: Urakawa, Ryuta, Isomura, Emiko Tanaka, Matsunaga, Kazuhide, Kubota, Kazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416095/
https://www.ncbi.nlm.nih.gov/pubmed/36016244
http://dx.doi.org/10.3390/vaccines10081357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416095/
https://www.ncbi.nlm.nih.gov/pubmed/36016244
http://dx.doi.org/10.3390/vaccines10081357

Ejemplares similares